The Patent Finder

Micro-RNAs and Compositions Comprising Same for the Treatment and Diagnosis of Serotonin-, Adrenalin-, Noradrenalin-, Glutamate-, and Corticotropin-Releasing Hormone- Associated Medical Conditions

Yeda Research and Development Co. Ltd.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 4 of these applications claim priority to application PCT/IB2012/053971, filed Aug 2, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,150,858Micro-RNAs and Compositions Comprising Same for the Treatment and Diagnosis of Serotonin-, Adrenalin-, Noradrenalin-, Glutamate-, and Corticotropin-Releasing Hormone- Associated Medical Conditions
In force
 · High confidence
Yeda Research and Development Co. Ltd.In force
High confidence
US 9,901,593Micro-RNAs and Compositions Comprising Same for the Treatment and Diagnosis of Serotonin-, Adrenalin-, Noradrenalin-, Glutamate-, and Corticotropin-Releasing Hormone- Associated Medical Conditions
In force
 · Medium confidence
Yeda Research and Development Co. Ltd.In force
Medium confidence
US 10,238,681Micro-RNAs and Compositions Comprising Same for the Treatment and Diagnosis of Serotonin-, Adrenalin-, Noradrenalin-, Glutamate-, and Corticotropin-Releasing Hormone- Associated Medical Conditions
In force
 · Medium confidence
Yeda Research and Development Co. Ltd.In force
Medium confidence
US 12,016,876Micro-RNAs and Compositions Comprising Same for the Treatment and Diagnosis of Serotonin-, Adrenalin-, Noradrenalin-, Glutamate-, and Corticotropin-Releasing Hormone- Associated Medical Conditions
In force
 · Medium confidence
Yeda Research and Development Co. Ltd.In force
Medium confidence
Application 16/273,215Micro-RNAs and Compositions Comprising Same for the Treatment and Diagnosis of Serotonin-, Adrenalin-, Noradrenalin-, Glutamate-, and Corticotropin-Releasing Hormone- Associated Medical Conditions
Abandoned
Abandoned Sep 16, 2022
Yeda Research and Development Co. Ltd.AbandonedAbandoned Sep 16, 2022
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Yeda Research and Development Co. Ltd..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited